Retatrutide Is Trending Again: What Triple-Agonist Data Means for Peptide Safety in 2026
Retatrutide is driving a new wave of peptide searches after Phase 3 weight-loss data. Alex Keane explains the triple-agonist science, safety signals, and why online peptide products deserve caution.
June 23, 20268 min read
Read Article ›